New Journal Website is available at:

Published by: Kowsar

Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction

Shokoufeh Hajsadeghi 1 , Mitra Chitsazan 2 , * , Mandana Chitsazan 3 , Majid Haghjoo 4 , Nima Babaali 5 , Zahra Norouzzadeh 1 and Maryam Mohsenian 1
Authors Information
1 Department of Cardiology, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran
2 Echocardiography Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
3 Department of Cardiology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Cardiac Electrophysiology Research Center, Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
5 Department of Cardiology, Rajaei Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Research in Cardiovascular Medicine: March 28, 2015, 4 (1); e25018
  • Published Online: March 20, 2015
  • Article Type: Research Article
  • Received: October 30, 2014
  • Accepted: December 29, 2014
  • DOI: 10.5812/cardiovascmed.25018

To Cite: Hajsadeghi S, Chitsazan M, Chitsazan M, Haghjoo M, Babaali N, et al. Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction, Res Cardiovasc Med. 2015 ;4(1):e25018. doi: 10.5812/cardiovascmed.25018.

Copyright: Copyright © 0, Research in Cardiovascular Medicine. .
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999; 159(10): 1104-9[PubMed]
  • 2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999; 83(9b): 25f-9f[PubMed]
  • 3. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998; 83(8): 2773-6[DOI][PubMed]
  • 4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996; 334(15): 952-7[DOI][PubMed]
  • 5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001; 285(19): 2486-97[PubMed]
  • 6. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983; 309(6): 331-6[DOI][PubMed]
  • 7. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation. 1995; 92(3): 334-41[PubMed]
  • 8. Panteghini M, Cuccia C, Bonetti G, Giubbini R, Pagani F, Bonini E. Single-point cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem. 2002; 48(9): 1432-6[PubMed]
  • 9. Mair J, Wagner I, Morass B, Fridrich L, Lechleitner P, Dienstl F, et al. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem. 1995; 33(11): 869-72[PubMed]
  • 10. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol. 2004; 43(12): 2253-9[DOI][PubMed]
  • 11. Thygesen K, Alpert JS, White HD, Joint EAFFTROMI. Universal definition of myocardial infarction. Eur Heart J. 2007; 28(20): 2525-38[DOI][PubMed]
  • 12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499-502[PubMed]
  • 13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006; 7(2): 79-108[DOI][PubMed]
  • 14. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL, et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004; 25(4): 342-8[DOI][PubMed]
  • 15. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol. 2004; 93(2): 159-64[PubMed]
  • 16. Turhan H, Erbay AR, Yasar AS, Bicer A, Sasmaz H, Yetkin E. Impaired coronary blood flow in patients with metabolic syndrome: documented by Thrombolysis in Myocardial Infarction (TIMI) frame count method. Am Heart J. 2004; 148(5): 789-94[DOI][PubMed]
  • 17. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005; 165(10): 1192-8[DOI][PubMed]
  • 18. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4): 683-9[PubMed]
  • 19. Logstrup BB, Hofsten DE, Christophersen TB, Moller JE, Botker HE, Pellikka PA, et al. Influence of abnormal glucose metabolism on coronary microvascular function after a recent myocardial infarction. JACC Cardiovasc Imaging. 2009; 2(10): 1159-66[DOI][PubMed]
  • 20. Fujimoto K, Hozumi T, Watanabe H, Tokai K, Shimada K, Yoshiyama M, et al. Acute hyperglycemia induced by oral glucose loading suppresses coronary microcirculation on transthoracic Doppler echocardiography in healthy young adults. Echocardiography. 2006; 23(10): 829-34[DOI][PubMed]
  • 21. Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003; 41(6): 1013-20[PubMed]
  • 22. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care. 2003; 26(11): 3129-35[PubMed]
  • 23. Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003; 290(16): 2174-81[DOI][PubMed]
  • 24. Wu AH, Parsons L, Every NR, Bates ER. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 2002; 40(8): 1389-94[PubMed]
  • 25. Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, Lopez-Sendon J, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004; 109(4): 494-9[DOI][PubMed]
  • 26. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med. 1997; 126(4): 296-306[PubMed]
  • 27. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol. 2004; 44(8): 1533-42[DOI][PubMed]
  • 28. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100(19): 1992-2002[PubMed]
  • 29. Jernberg T, James S, Lindahl B, Stridsberg M, Venge P, Wallentin L. NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail. 2004; 6(3): 319-25[DOI][PubMed]
  • 30. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation. 2004; 110(2): 128-34[DOI][PubMed]
  • 31. Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol. 2003; 41(8): 1264-72[PubMed]
  • 32. Al Saady NM, Camm AJ. Myocardial damage. Early detection by novel biochemical markers. 1998; : 137-48
  • 33. Grande P, Christiansen C, Alstrup K. Comparison of ASAT, CK, CK-MB, and LD for the estimation of acute myocardial infarct size in man. Clin Chim Acta. 1983; 128(2-3): 329-35[PubMed]
  • 34. Pride YB, Giuseffi JL, Mohanavelu S, Harrigan CJ, Manning WJ, Gibson CM, et al. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct. Am J Cardiol. 2010; 106(5): 635-40[DOI][PubMed]
  • 35. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991; 67(16): 1360-7[PubMed]
  • 36. Remppis A, Ehlermann P, Giannitsis E, Greten T, Most P, Muller-Bardorff M, et al. Cardiac troponin T levels at 96 hours reflect myocardial infarct size: a pathoanatomical study. Cardiology. 2000; 93(4): 249-53[PubMed]
  • 37. Gallegos RP, Swingen C, Xu XJ, Wang X, Bianco R, Jerosch-Herold M, et al. Infarct extent by MRI correlates with peak serum troponin level in the canine model. J Surg Res. 2004; 120(2): 266-71[DOI][PubMed]
  • 38. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart. 2002; 87(6): 520-4[PubMed]
  • 39. Steen H, Futterer S, Merten C, Junger C, Katus HA, Giannitsis E. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. J Cardiovasc Magn Reson. 2007; 9(5): 749-58[DOI][PubMed]
  • 40. Steen H, Giannitsis E, Futterer S, Merten C, Juenger C, Katus HA. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol. 2006; 48(11): 2192-4[DOI][PubMed]
  • 41. Grande P, Christiansen C, Hansen BF. Myocardial infarct size and cardiogenic shock. Eur Heart J. 1983; 4(5): 289-94[PubMed]
  • 42. Christenson RH, Vollmer RT, Ohman EM, Peck S, Thompson TD, Duh SH, et al. Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. Am J Cardiol. 2000; 85(5): 543-7[PubMed]
  • 43. Turer AT, Mahaffey KW, Gallup D, Weaver WD, Christenson RH, Every NR, et al. Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction. Curr Control Trials Cardiovasc Med. 2005; 6: 12[DOI][PubMed]
  • 44. Nienhuis MB, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, et al. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am Heart J. 2008; 155(4): 673-9[DOI][PubMed]
  • 45. Grande P, Christiansen C, Pedersen A. Influence of acute myocardial infarct size on acute and one-year mortality. Eur Heart J. 1983; 4(1): 20-5[PubMed]
  • 46. Grande P, Nielsen A, Wagner GS, Christiansen C. Quantitative influence of serum creatine kinase isoenzyme MB estimated infarct size and other prognostic variables on one year mortality after acute myocardial infarction. Br Heart J. 1985; 53(1): 9-15[PubMed]
  • 47. Halkin A, Stone GW, Grines CL, Cox DA, Rutherford BD, Esente P, et al. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2006; 47(5): 951-61[DOI][PubMed]
  • 48. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med. 2006; 7(1): 7-11[DOI][PubMed]
  • 49. Kranjcec D, Altabas V. Metabolic syndrome influencing infarct size and heart failure in patients with acute coronary syndrome: does gender matter? Endocr J. 2012; 59(12): 1065-76[PubMed]
  • 50. Bohmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S. The association between metabolic syndrome and infarct size in patients with acute myocardial infarction. Scand J Clin Lab Invest. 2010; 70(4): 287-93[DOI][PubMed]
  • 51. Penjaskovic D, Sakac D, Dejanovic J, Zec R, Zec Petkovic N, Stojsic Milosavljevic A. Left ventricular diastolic dysfunction in patients with metabolic syndrome. Med Pregl. 2012; 65(1-2): 18-22[PubMed]
  • 52. Khan AR, Khan MQ. Association and pattern of diastolic dysfunction in patients of metabolic syndrome. J Ayub Med Coll Abbottabad. 2008; 20(2): 70-5[PubMed]
  • 53. Lebeau R, Serri K, Morice MC, Hovasse T, Unterseeh T, Piechaud JF, et al. Assessment of left ventricular ejection fraction using the wall motion score index in cardiac magnetic resonance imaging. Arch Cardiovasc Dis. 2012; 105(2): 91-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader